Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)

Completed · Phase 4 · Has a placebo group

Conditions studied: Invasive Candidiasis

In brief

Adults admitted to intensive care units are at risk for a variety of complications. Infections due to the fungus called candida are of particular concern. The study will test the possibility that caspofungin, a new therapy for fungal infections, can successfully reduce the rate of candida infections in subjects at risk. It will also test if caspofungin is useful in treating subjects for this disease when diagnosed using a new blood test that is performed twice weekly, permitting earlier diagnosis than current practice standards.

Key facts

Study ID

NCT00520234

Run by

Mycoses Study Group

People needed

222

Starts

2007-08-01

Expected to finish

2010-03-01

Last updated by the study team

2011-05-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Non-pregnant >18 yrs of age
• Subjects admitted to ICU during the preceding 3 days and expected to stay in the ICU for at least another 48 hours.Subjects can be enrolled on days 3-5 of ICU admission.
• Subjects meeting the clinical prediction rule

You may not qualify if…

• Subjects with an allergy/intolerance to caspofungin or echinocandin analog
• absolute neutrophil count <500/mm3 at study entry or likely to develop such a count during therapy
• acquired immunodeficiency syndrome, aplastic anemia or chronic granulomatous disease
• moderate or severe hepatic insufficiency
• subjects who are pregnant or lactating
• unlikely to survive < 24 hours
• subjects who have received systemic antifungal therapy within 10 days prior to study entry
• Documented active proven or probable invasive fungal infection upon enrollment
• previously enrolled in this study
• Currently on another investigational agent or have received an investigational agent within 10 days prior to study entry.

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States
• University of Southern California — Los Angeles, California, United States
• University of Colorado — Denver, Colorado, United States
• Washington Hospital Center — Washington D.C., District of Columbia, United States
• Tulane University — New Orleans, Louisiana, United States
• Harper University Hospital/ Wayne State — Detroit, Michigan, United States
• Henry Ford Hospital — Detroit, Michigan, United States
• St. Patrick's Hospital — Missoula, Montana, United States
• Cooper University Hospital — Camden, New Jersey, United States
• The Ohio State University — Columbus, Ohio, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Medical Center of South Carolina — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.